Histopathology of the tumors and expression of tumor markers CD99, SPARC, and MyoD1 did not change significantly upon successive mouse‐to‐mouse passaging in 12 PDX models studied by IHC (Figure 1). This evidence concerns the gene SPARC and neoplasm.